论文部分内容阅读
经皮冠状动脉介入治疗作为有创性的操作,术中及术后可能发生血管性并发症,如急性冠状动脉狭窄或闭塞、穿孔和心脏压塞、冠脉无再流现象、穿刺产生的血栓、血肿或假性动脉瘤、动-静脉瘘以及非血管性并发症(如低血压、急性冠脉痉挛、心室纤颤、血管迷走反射和造影剂肾病)等。并发症一旦发生,不但严重影响手术的效果,甚至直接导致手术的失败。目前对上述并发症的防治虽然取得不少进展,但这些并发症仍然是影响经皮冠状动脉介入治疗疗效的关键因素之一。
Percutaneous coronary intervention as an invasive procedure may lead to vascular complications during and after surgery such as acute coronary stenosis or occlusion, perforation and cardiac tamponade, coronary no-reflow phenomenon, puncture-generated thrombus , Hematoma or pseudoaneurysms, arteriovenous fistulas and non-vascular complications such as hypotension, acute coronary spasm, ventricular fibrillation, vasovagal reflex and contrast agent nephropathy. Complications in the event of serious consequences not only the operation, and even directly led to the failure of surgery. Although the prevention and treatment of the above complications have made a lot of progress, these complications are still one of the key factors that affect the efficacy of percutaneous coronary intervention.